Get the Stockscreener App
1.14
2.56%
-0.03
Protalix BioTherapeutics Inc. Stock (PLX) Forecast
The Protalix BioTherapeutics Inc. (PLX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.3942, representing a +22.30% increase from the current price of $1.14. The highest analyst price target is $2.3007, and the lowest is $0.4877.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PLX Price Target
Average 1.1574
(+1.53% Upside)
Is Protalix BioTherapeutics Inc. (PLX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.41 | Neutral |
| STOCH(9,6) | 49.82 | Neutral |
| STOCHRSI(14) | 43.68 | Neutral |
| MACD(12,26) | -0.0232 | Buy |
| ADX(14) | 21.57 | Neutral |
| William %R | -50.18 | Neutral |
| CCI(14) | -19.70 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.148
Sell
|
1.1518
Sell
|
| MA20 |
1.1625
Sell
|
1.1647
Sell
|
| MA50 |
1.2276
Sell
|
1.2367
Sell
|
| MA100 |
1.3965
Sell
|
1.3455
Sell
|
| MA200 |
1.5274
Sell
|
1.5151
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PLX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on PLX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.41 indicates that PLX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 49.82 indicates that PLX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 43.68 indicates that PLX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.57 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -19.7 indicates that PLX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PLX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Protalix BioTherapeutics Inc. financial reports and earnings history, Protalix BioTherapeutics Inc. (PLX) stock could reach $1.6494 by 2030, $1.6098 by 2040 and $7.9479 by 2050. See the projected annual prices until 2050 of the Protalix BioTherapeutics Inc. stock below:
- Protalix BioTherapeutics Inc. (PLX) is expected to reach an average price of $0.6638 in 2035, with a high prediction of $0.6388 and a low estimate of $0.5354. This indicates an $-41.77% rise from the last recorded price of $1.14.
- Protalix BioTherapeutics Inc. (PLX) stock is projected to chart a bullish course in 2040, with an average price target of $1.0675, representing an $-6.36% surge from its current level. The forecast ranges from a conservative $1.4775 to a sky-high $1.6098.
- Our analysts predict Protalix BioTherapeutics Inc. (PLX) to jump 339.00% by 2045, soaring from $5.0046 to an average price of $5.0046, potentially reaching $4.9824. While $5.0046 is the low estimate, the potential upside is significant.
- Protalix BioTherapeutics Inc. (PLX) stock is expected to climb by 2050, reaching an average of $7.649, a $570.97% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.9479 and $7.8485, respectively, highlighting the market's uncertainty.
Protalix BioTherapeutics Inc. Stock (PLX) Year by Year Forecast
Protalix BioTherapeutics Inc. Stock (PLX) Price Forecast for 2024
Our forecast for PLX stock price in 2024 now indicates an average price target of $1.28 with a high forecast of $2.3007 and a low forecast of $0.2593. The average prediction reflects an increase of +12.28% from the last recorded price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.7575 | $0.4877 | $2.3007 | +54.17% |
| July, 2024 | $0.9151 | $0.5932 | $1.9644 | -19.72% |
| August, 2024 | $0.3271 | $0.4791 | $1.0001 | -71.30% |
| September, 2024 | $0.6394 | $0.7222 | $0.4653 | -43.91% |
| October, 2024 | $0.1572 | $0.7876 | $1.9372 | -86.21% |
| November, 2024 | $0.4881 | $0.446 | $0.353 | -57.19% |
| December, 2024 | $0.4127 | $0.2593 | $0.9387 | -63.80% |
Protalix BioTherapeutics Inc. Stock (PLX) Price Forecast for 2025
Protalix BioTherapeutics Inc. Stock (PLX) is expected to reach an average price of $1.1711 in 2025, with a high prediction of $2.328 and a low estimate of $0.0142. This indicates an +2.73% rise from the last recorded price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.2833 | $0.0544 | $1.4633 | +12.57% |
| February, 2025 | $1.071 | $0.781 | $2.2322 | -6.05% |
| March, 2025 | $0.7788 | $0.6649 | $1.6018 | -31.68% |
| April, 2025 | $0.1866 | $0.2366 | $1.0103 | -83.63% |
| May, 2025 | $1.2826 | $0.0142 | $1.7611 | +12.51% |
| June, 2025 | $0.4688 | $0.3288 | $2.328 | -58.88% |
| July, 2025 | $1.7634 | $0.3757 | $1.8834 | +54.69% |
| August, 2025 | $1.0812 | $1.0163 | $1.7404 | -5.16% |
| September, 2025 | $1.2189 | $0.9381 | $1.745 | +6.92% |
| October, 2025 | $1.0635 | $1.0135 | $1.8658 | -6.71% |
| November, 2025 | $1.5412 | $0.9805 | $1.7212 | +35.20% |
| December, 2025 | $0.9759 | $0.8559 | $1.6752 | -14.40% |
Protalix BioTherapeutics Inc. Stock (PLX) Price Forecast for 2026
The predicted value for Protalix BioTherapeutics Inc. (PLX) in 2026 is set at an average of $2.4406. Estimates vary from a peak of $4.8367 to a trough of $0.0445, indicating an +114.09% surge from the present price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3536 | $0.8328 | $1.7836 | +18.74% |
| February, 2026 | $1.2413 | $1.0113 | $1.7613 | +8.89% |
| March, 2026 | $1.959 | $1.1482 | $2.089 | +71.84% |
| April, 2026 | $2.9337 | $2.0529 | $4.8367 | +157.34% |
| May, 2026 | $2.9514 | $1.6575 | $3.7106 | +158.89% |
| June, 2026 | $3.1391 | $2.2603 | $3.3383 | +175.36% |
| July, 2026 | $0.6538 | $0.5238 | $4.5399 | -42.65% |
| August, 2026 | $0.1115 | $0.0445 | $1.0088 | -90.22% |
| September, 2026 | $0.2939 | $0.1216 | $0.2284 | -74.22% |
| October, 2026 | $0.5062 | $0.457 | $0.3731 | -55.60% |
| November, 2026 | $0.3285 | $0.4484 | $0.5423 | -71.19% |
| December, 2026 | $0.6138 | $0.4015 | $0.5507 | -46.16% |
Protalix BioTherapeutics Inc. Stock (PLX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Protalix BioTherapeutics Inc. (PLX) is $0.6571, with a high forecast of $0.9522 and a low forecast of $0.3621. This indicates an -42.36% decrease from the last price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.7461 | $0.71 | $0.6661 | -34.55% |
| February, 2027 | $0.8984 | $0.7953 | $0.7392 | -21.19% |
| March, 2027 | $0.9699 | $0.9635 | $0.9231 | -14.92% |
| April, 2027 | $0.9562 | $0.9829 | $0.896 | -16.12% |
| May, 2027 | $0.7583 | $0.9483 | $0.9522 | -33.48% |
| June, 2027 | $0.8737 | $0.8809 | $0.9056 | -23.36% |
| July, 2027 | $0.6659 | $0.7329 | $0.8467 | -41.58% |
| August, 2027 | $0.5082 | $0.3621 | $0.619 | -55.42% |
| September, 2027 | $0.5236 | $0.5913 | $0.5474 | -54.07% |
| October, 2027 | $0.5459 | $0.4897 | $0.5259 | -52.12% |
| November, 2027 | $0.4982 | $0.5451 | $0.5251 | -56.30% |
| December, 2027 | $0.3485 | $0.4835 | $0.4874 | -69.43% |
Protalix BioTherapeutics Inc. Stock (PLX) Price Forecast for 2028
In 2028, Protalix BioTherapeutics Inc. (PLX) is projected to reach an average price of $1.1622, with a high projection of $2.2744 and a low estimate of $0.05. This indicates an +1.95% rise from the last price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4558 | $0.3966 | $0.4258 | -60.02% |
| February, 2028 | $0.4767 | $0.4919 | $0.4589 | -58.19% |
| March, 2028 | $0.4534 | $0.4634 | $0.4442 | -60.23% |
| April, 2028 | $0.2607 | $0.4157 | $0.4279 | -77.13% |
| May, 2028 | $0.2411 | $0.2711 | $0.2919 | -78.85% |
| June, 2028 | $0.2766 | $0.05 | $0.3466 | -75.73% |
| July, 2028 | $0.2144 | $0.0714 | $0.3074 | -81.20% |
| August, 2028 | $0.519 | $0.1013 | $0.879 | -54.47% |
| September, 2028 | $0.9067 | $0.4259 | $0.9967 | -20.46% |
| October, 2028 | $1.9944 | $0.9436 | $2.2744 | +74.95% |
| November, 2028 | $0.9691 | $0.6522 | $2.0414 | -14.99% |
| December, 2028 | $0.7868 | $0.7568 | $1.271 | -30.98% |
Protalix BioTherapeutics Inc. Stock (PLX) Price Forecast for 2029
The 2029 price forecast for Protalix BioTherapeutics Inc. Stock (PLX) is $0.7431 on average, with a high prediction of $1.337 and a low estimate of $0.1492. This represents an -34.81% decrease from the previous price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4214 | $0.2395 | $0.7637 | -63.03% |
| February, 2029 | $0.7792 | $0.3984 | $0.9322 | -31.65% |
| March, 2029 | $0.6469 | $0.5869 | $0.8777 | -43.26% |
| April, 2029 | $0.3846 | $0.3246 | $0.6738 | -66.26% |
| May, 2029 | $0.2792 | $0.1492 | $0.8023 | -75.51% |
| June, 2029 | $0.4269 | $0.2162 | $0.4869 | -62.55% |
| July, 2029 | $0.7747 | $0.4139 | $0.8947 | -32.05% |
| August, 2029 | $0.4793 | $0.4624 | $0.8516 | -57.96% |
| September, 2029 | $0.507 | $0.4601 | $0.5901 | -55.52% |
| October, 2029 | $0.3617 | $0.3517 | $0.7509 | -68.27% |
| November, 2029 | $0.2694 | $0.2094 | $0.4625 | -76.37% |
| December, 2029 | $1.68 | $0.2163 | $1.337 | +47.37% |
Protalix BioTherapeutics Inc. Stock (PLX) Price Forecast for 2030
Protalix BioTherapeutics Inc. Stock (PLX) is expected to reach an average price of $2.2958 in 2030, with a high forecast of $3.3974 and a low forecast of $1.1941. This signifies an +101.38% surge from the last price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5107 | $1.7107 | $1.6494 | +32.52% |
| February, 2030 | $1.3923 | $1.1941 | $1.2063 | +22.13% |
| March, 2030 | $1.9258 | $1.9414 | $1.8097 | +68.93% |
| April, 2030 | $3.4444 | $3.2583 | $3.0464 | +202.14% |
| May, 2030 | $3.3921 | $3.4917 | $3.3221 | +197.56% |
| June, 2030 | $3.1687 | $3.4087 | $3.3974 | +177.96% |
| July, 2030 | $2.8464 | $3.142 | $3.1473 | +149.68% |
| August, 2030 | $2.735 | $2.3727 | $2.395 | +139.91% |
| September, 2030 | $1.1696 | $1.3395 | $2.1411 | +2.60% |
| October, 2030 | $1.8403 | $1.6741 | $1.4868 | +61.43% |
| November, 2030 | $2.7548 | $1.8625 | $2.1848 | +141.65% |
| December, 2030 | $2.8194 | $2.7733 | $2.7195 | +147.32% |
0.77%
1.20%
Cap:
|
Volume (24h):